Uri Ashery's Lab

Sade O, Boneberg R, Weiss Y, Beldjilali-Labro M, Leichtmann-Bardoogo Y, Talpir I, et al. Super-Resolution-Chip: an in-vitro platform that enables super-resolution  microscopy of co-cultures and 3D systems. Biomed Opt Express 2023; 14: 5223–37.

Sela M, Poley M, Mora-Raimundo P, Kagan S, Avital A, Kaduri M, et al. Brain-Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha-Synuclein  Aggregation and Improve Behavioral Symptoms in Parkinson’s Disease. Adv Mater 2023; 35: e2304654.

Shahoha M, Cohen R, Ben-Simon Y, Ashery U. cAMP-Dependent Synaptic Plasticity at the Hippocampal Mossy Fiber Terminal. Front Synaptic Neurosci 2022; 14

Arpino G, Somasundaram A, Shin W, Ge L, Villareal S, Chan CY, et al. Clathrin-mediated endocytosis cooperates with bulk endocytosis to generate  vesicles. iScience 2022; 25: 103809.

Rauti R, Shahoha M, Leichtmann-Bardoogo Y, Nasser R, Paz E, Tamir R, et al. Effect of SARS-CoV-2 proteins on vascular permeability. Elife 2021; 10

Shvarts-Serebro I, Sheinin A, Gottfried I, Adler L, Schottlender N, Ashery U, et al. miR-128 as a Regulator of Synaptic Properties in 5xFAD Mice Hippocampal Neurons. J Mol Neurosci 2021

Shapira R, Gdalyahu A, Gottfried I, Sasson E, Hadanny A, Efrati S, et al. Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer’s disease mouse model and in elderly patients. Aging (Albany NY) 2021; 13: 20935.

Schottlender N, Gottfried I, Ashery U. Hyperbaric Oxygen Treatment: Effects on Mitochondrial Function and Oxidative  Stress. Biomolecules 2021; 11

Gottfried I, Schottlender N, Ashery U. Hyperbaric oxygen treatment—from mechanisms to cognitive improvement. Biomolecules 2021; 11: 1–11.

Kondratiuk I, Jakhanwal S, Jin J, Sathyanarayanan U, Kroppen B, Pobbati A V., et al. PI(4,5)P 2 -dependent regulation of exocytosis by amisyn, the vertebrate-specific competitor of synaptobrevin 2. Proc Natl Acad Sci 2020: 201908232.

Perets N, Betzer O, Shapira R, Brenstein S, Angel A, Sadan T, et al. Golden Exosomes Selectively Target Brain Pathologies in Neurodegenerative and Neurodevelopmental Disorders. Nano Lett 2019: acs.nanolett.8b04148.

Wegrzynowicz M, Bar-On D, Calo’ L, Anichtchik O, Iovino M, Xia J, et al. Depopulation of dense α-synuclein aggregates is associated with rescue of  dopamine neuron dysfunction and death in a new Parkinson’s disease model. Acta Neuropathol 2019; 138: 575–95.

Shapira R, Solomon B, Efrati S, Frenkel D, Ashery U. Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation. Neurobiol Aging 2018; 62: 105–19.

Shapira R, Efrati S, Ashery U. Hyperbaric oxygen therapy as a new treatment approach for Alzheimer’s disease. Neural Regen Res 2018; 13

Michaeli L, Gottfried I, Bykhovskaia M, Ashery U. Phosphatidylinositol (4, 5)‐bisphosphate targets double C2 domain protein B to the plasma membrane. Traffic 2017; 18: 825–39.